Table 3.
Perceptions of SARS-CoV-2 vaccine information sources among participants
| Information source | Sex (n = 1179) |
P-value | Willingness to be vaccinated against COVID-19 (n = 1179) |
P-value | Education level (n = 1179) |
P-value | |||
|---|---|---|---|---|---|---|---|---|---|
| Males (n = 574) | Females (n = 605) | Yes (n = 912) | No (n = 267) | Secondary level (n = 156) | Higher qualification (n = 1023) | ||||
| Good/excellent source | |||||||||
| Internet, n (%) | 519 (90.4) | 552 (91.2) | 0.686 | 828 (90.8) | 243 (91.0) | 0.912 | 139 (89.1) | 932 (91.1) | .455 |
| Media, n (%) | 515 (89.7) | 521 (86.1) | 0.061 | 822 (90.1) | 214 (80.1) | <0.001 | 131 (84.0) | 905 (88.5) | .115 |
| Visits to healthcare providers, n (%) | 543 (94.6) | 568 (93.9) | 0.619 | 874 (95.8) | 237 (88.8) | <0.001 | 151 (96.8) | 960 (93.8) | .194 |
| Printed materials from healthcare providers, n (%) | 516 (89.9) | 552 (91.2) | 0.485 | 839 (92.0) | 229 (85.8) | 0.004 | 147 (94.2) | 921 (90.0) | .106 |
| Alternative healthcare providers, n (%) | 534 (93.0) | 562 (92.9) | 0.926 | 853 (93.5) | 243 (91.0) | 0.173 | 145 (92.9) | 951 (93.0) | .995 |
| Vaccine companies and industry, n (%) | 169 (29.4) | 171 (28.3) | 0.700 | 247 (27.1) | 93 (34.8) | 0.017 | 48 (30.8) | 292 (28.5) | .570 |
| Family members, n (%) | 540 (94.1) | 576 (95.2) | 0.438 | 867 (95.1) | 249 (93.3) | 0.278 | 145 (92.9) | 971 (94.9) | .337 |
| Friends, n (%) | 537 (93.6) | 578 (95.5) | 0.157 | 861 (94.4) | 254 (95.1) | 0.759 | 148 (94.9) | 967 (94.5) | .859 |